Ribavirin as a potential therapeutic for atypical teratoid/rhabdoid tumors

Joshua Casaos(Johns Hopkins University), Betty Tyler(Johns Hopkins University), Thomas Simon(University of Southern California), Raphael Felder(Johns Hopkins University), Richard E. Kast, Julie Sesen(Boston Children's Hospital), Tianna Zhao(Leidos (United States)), Charles G. Eberhart(Johns Hopkins University), Russell Maxwell(Johns Hopkins University), T. B. Lott(Johns Hopkins University), John Choi(Stanford University), Sakibul Huq(Johns Hopkins University), Henry Brem(Johns Hopkins University), Eric H. Raabe(Johns Hopkins University), Jeffrey Rubens(Johns Hopkins University), Yuanxuan Xia(Johns Hopkins University), Noah Gorelick(Johns Hopkins University), Michael Peters(Johns Hopkins University), Sarah Scotland(Massachusetts Department of Public Health), Eric M. Jackson(Johns Hopkins University), Chenchen Ji(Johns Hopkins University)
Oncotarget
January 3, 2018
Cited by 21


Related Papers